Neumora Therapeutics, Inc. (NMRA)

3.47 +0.08 (+2.36%) USD  |  NASDAQ  |  Feb 23, 11:22
More

Neumora Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for NMRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Ventyx Biosciences, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Puma Biotechnology, Inc. Upgrade
Nautilus Biotechnology, Inc. Upgrade
ProKidney Corp. Upgrade